Pushing peptides

Synopsis

Peptides — injectable chains of amino acids being marketed for everything from weight loss to joint repair to anti-aging — have exploded into a multi-million dollar gray market, with Americans buying unregulated compounds directly from Chinese factories through Discord servers and WhatsApp. New York Magazine reporter Ezra Marcus bought a next-generation GLP-1 drug (Retatrutide, not yet FDA-approved) for $150 in Bitcoin, had it shipped disguised as face masks from the Philippines, tested it, and injected it — and it worked. The FDA's 2023 crackdown on roughly a dozen peptides didn't stop demand; it just pushed consumers toward gray and black markets, and now RFK Jr. is signaling a regulatory reversal that could bring production back to U.S. compounding pharmacies. For any professional tracking the next wave after Ozempic, this episode maps exactly how a substance moves from Chinese factory floor to American bloodstream — and why the regulatory moment unfolding right now could determine whether peptides become the next billion-dollar health category or a public safety crisis.

Speakers

Episode Breakdown